Seromic mucin signature for the early diagnosis of pancreatic cancer
Ended Project Grant Awarded Last action
- Award ID
- R44CA224619
- Recipient
-
Sanguine Diagnostics & Therapeutics Inc. UEI ECGMLSHGH4X6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,452,790
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Omaha, NE 68106, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$44,571 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $650,357 | |
| Amendment | $56,751 | |
| Amendment | -$56,751 | |
| Amendment | $650,357 | |
| Amendment | $0 | |
| Original award | $196,647 |
Show all 18
Quick answers
Who received award R44CA224619?
R44CA224619 was awarded to Sanguine Diagnostics & Therapeutics Inc. by National Cancer Institute (National Institutes of Health) on March 1, 2018.
How much is award R44CA224619 worth?
$1,452,790 has been obligated on R44CA224619.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award